参考文献/References:
[1] Cantara S, Marzocchi C, Pilli T, et al.Molecular signature of indeterminate thyroid lesions: Current methods to improve Fine Needle Aspiration Cytology (FNAC) diagnosis[J].Int J Mol Sci,2017,18(4):775.
[2] 张永生,王萍萍,高萍,等.免疫组化技术在甲状腺液基细胞学诊断为Ⅲ类-意义不明确细胞非典型病变中的应用价值[J].现代肿瘤医学,2021,29(11):1875-1879.
[3] Cibas E S, Ali S Z.The 2017 Bethesda system for reporting thyroid cytopathology [J].Thyroid,2017,27(11):1341-1346.
[4] 黎三艳,陈虹,王行富,等.膀胱乳头状尿路上皮肿瘤中CD10和CK20的表达[J].临床与实验病理学杂志,2016,32(10):1113-1117.
[5] Vaccarella S, Franceschi S, Bray F, et al.Worldwide thyroid-cancer epidemic? The increasing impact of over diagnosis[J].N Engl J Med,2016,375(7):614-617.
[6] Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[7] Rossi E D, Raffaelli M, Zannoni G F, et al.Diagnostic efficacy of conventional as compared to liquid-based cytology in thyroid lesions: evaluation of 10,360 fine needle aspiration cytology cases[J].Acta Cytol,2009,53(6):659-666.
[8] Cibas E S, Ali S Z.The Bethesda system for reporting thyroid cytopathology[J].Thyroid,2009,19(11):1159-1165.
[9] 林建龙,钟国栋,王鸿程,等.2386例甲状腺细针穿刺液基细胞学病理诊断分析[J].诊断病理学杂志,2018,25(2):112-117.
[10] Bartolazzi A, Gasbarri A, Papotti M, et al.Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions[J].Lancet,2001,357(9269):1644-1650.
[11] Sapio M R, Guerra A, Posca D, et al.Combined analysis of galectin-3 and BRAFV600E improves the accuracy of fine-needle aspiration biopsy with cytological findings suspicious for papillary thyroid carcinoma[J].Endocr Relat Cancer,2007,14(4):1089-1097.
[12] Bryson P C, Shores C G, Hart C, et al.Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas[J].Arch Otolaryngol Head Neck Surg,2008,134(6):581-586.
[13] Torregrossa L, Faviana P, Filice M E, et al.CXC chemokine receptor 4 immunodetection in the follicular variant of papillary thyroid carcinoma: comparison to galectin-3 and hector battifora mesothelial cell-1[J].Thyroid,2010,20(5):495-504.
[14] Zhang L, Krausz T, Demay R M.A pilot study of Galectin-3, HBME-1, and p27 triple immunostaining pattern for diagnosis of indeterminate thyroid nodules in cytology with correlation to histology[J].Appl Immunohistochem Mol Morphol,2015,23(7):481-490.
[15] Xin Y, Guan D, Meng K, et al.Diagnostic accuracy of CK-19, Galectin-3 and HBME-1 on papillary thyroid carcinoma: a meta-analysis [J].Int J Clin Exp Pathol,2017,10(8):8130-8140.
[16] Funasaka T, Raz A, Nangia-Makker P.Galectin-3 in angiogenesis and metastasis [J].Glycobiology,2014,24(10):886-891.
[17] 叶丹,章佳波,姚玲莉,等.CyclinD1、p27表达与甲状腺微小乳头状癌中央区淋巴结转移超声特征的关系[J].临床荟萃,2021,36(3):262-265.
[18] Khoo M L, Beasley N J, Ezzat S, et al.Overexpression of cyclin D1 and underexpression of p27 predict lymph node metastases in papillary thyroid carcinoma [J].J Clin Endocrinol Metab,2002,87(4):1814-1818.